Ma Ka Wing, Cheung Tan To
Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Pok Fu Lam, Hong Kong.
J Hepatocell Carcinoma. 2016 Dec 28;4:1-9. doi: 10.2147/JHC.S96085. eCollection 2017.
Localized hepatocellular carcinoma (HCC) refers to a solitary or few tumors located within either the left or right hemiliver without evidence of bilobar or extrahepatic spread. This term encompasses a heterogeneous morphology with no regard to stage of prognosis of the disease. Surgical resection remains the mainstay of curative treatment for the localized HCC. Various biochemical and radiological tests constitute an indispensible part of preoperative assessment. Emergence of laparoscopic hepatectomy has brought liver resection into a new era. Improved understanding of the pathophysiology of HCC allows more aggressive surgical resection without compromising outcomes. New insights into the management of special situations, such as ruptured HCC, pyogenic transformation of HCC, and HCC with portal vein tumor thrombus, rekindle the hopes of curative resection in these terminal events. Amalgamating salvage liver transplantation into the surgical management of resectable HCC has revolutionized the treatment paradigm of this deadly disease.
局限性肝细胞癌(HCC)是指位于肝左叶或右叶内的单个或少数肿瘤,无双侧或肝外扩散的证据。该术语涵盖了异质性形态,而不考虑疾病的预后阶段。手术切除仍然是局限性HCC根治性治疗的主要方法。各种生化和放射学检查是术前评估不可或缺的一部分。腹腔镜肝切除术的出现使肝切除进入了一个新时代。对HCC病理生理学的深入了解使得在不影响预后的情况下能够进行更积极的手术切除。对特殊情况(如破裂性HCC、HCC的化脓性转化和伴有门静脉肿瘤血栓的HCC)管理的新见解,重新点燃了在这些终末期事件中进行根治性切除的希望。将挽救性肝移植纳入可切除HCC的外科治疗中,彻底改变了这种致命疾病的治疗模式。